THERAGENICS CORP (TGX) financial statements (2021 and earlier)

Company profile

Business Address 5203 BRISTOL INDUSTRIAL WAY
BUFORD, GA 30518
State of Incorp. DE
Fiscal Year End December 31
SIC 3825 - Instruments for Measuring and Testing of Electricity and Electrical Signals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments35
Cash and cash equivalents24
Short-term investments11
Receivables9
Inventory, net of allowances, customer advances and progress billings15
Inventory15
Prepaid expense and other current assets1
Income taxes receivable0
Other undisclosed current assets1
Total current assets:62
Noncurrent Assets
Property, plant and equipment32
Intangible assets, net (including goodwill)11
Intangible assets, net (excluding goodwill)11
Prepaid expense and other noncurrent assets0
Deferred tax assets, net1
Total noncurrent assets:44
TOTAL ASSETS:106
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5
Accounts payable2
Employee-related liabilities3
Other liabilities1
Total current liabilities:6
Noncurrent Liabilities
Long-term debt and lease obligation22
Long-term debt, excluding current maturities22
Liabilities, other than long-term debt1
Asset retirement obligations1
Other liabilities0
Total noncurrent liabilities:23
Total liabilities:29
Stockholders' equity
Stockholders' equity attributable to parent77
Common stock0
Treasury stock, value(10)
Additional paid in capital76
Accumulated other comprehensive income0
Retained earnings11
Total stockholders' equity:77
TOTAL LIABILITIES AND EQUITY:106

Income statement (P&L) ($ in millions)

12/31/2012
Revenues
(Revenue, Net)
83
Cost of revenue
(Cost of Goods and Services Sold)
(52)
Gross profit:31
Operating expenses(27)
Operating income:4
Nonoperating expense(0)
Investment income, nonoperating0
Interest and debt expense(1)
Income from continuing operations before equity method investments, income taxes:3
Other undisclosed income from continuing operations before income taxes1
Income from continuing operations before income taxes:3
Income tax expense(1)
Net income available to common stockholders, diluted:2

Comprehensive Income ($ in millions)

12/31/2012
Net income:2
Comprehensive income:2
Other undisclosed comprehensive income, net of tax, attributable to parent0
Comprehensive income, net of tax, attributable to parent:2

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: